Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NK

NantKwest (NK) Stock Price, News & Analysis

NantKwest logo

About NantKwest Stock (NASDAQ:NK)

Advanced Chart

Key Stats

Today's Range
$2.23
$2.35
50-Day Range
$16.09
$38.70
52-Week Range
$2.52
$45.42
Volume
9.56 million shs
Average Volume
1.57 million shs
Market Capitalization
$252.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantKwest and its competitors with MarketBeat's FREE daily newsletter.

NK Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”tc pixel
Space Nk Promo Codes
See More Headlines

NK Stock Analysis - Frequently Asked Questions

NantKwest, Inc. (NASDAQ:NK) issued its quarterly earnings results on Monday, May, 11th. The biotechnology company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.02. The biotechnology company had revenue of $0.02 million for the quarter. NantKwest had a negative trailing twelve-month return on equity of 56.06% and a negative net margin of 76,658.58%.

NantKwest (NK) raised $150 million in an initial public offering (IPO) on Tuesday, July 28th 2015. The company issued 7,000,000 shares at $20.00-$23.00 per share. BofA Merrill Lynch, Citigroup, Jefferies and Piper Jaffray acted as the underwriters for the IPO and MLV & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that NantKwest investors own include Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Dynavax Technologies (DVAX) and OPKO Health (OPK).

Company Calendar

Last Earnings
5/11/2020
Today
8/22/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:NK
CIK
1326110
Fax
N/A
Employees
160
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.79 million
Net Margins
-76,658.58%
Pretax Margin
N/A
Return on Equity
-56.06%
Return on Assets
-46.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.74
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
6,123.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.23 per share
Price / Book
1.82

Miscellaneous

Outstanding Shares
109,345,000
Free Float
N/A
Market Cap
$244.93 million
Optionable
Not Optionable
Beta
2.61
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:NK) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners